Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer
Author:
Affiliation:
1. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Publisher
The Korean Society of Gastroenterology
Subject
General Medicine
Link
https://synapse.koreamed.org/pdf/10.4166/kjg.2015.66.3.150
Reference21 articles.
1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
2. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
3. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
4. Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
5. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Case of Complete Remission from Pancreatic Cancer Following Palliative Chemotherapy;The Korean Journal of Pancreas and Biliary Tract;2023-10-31
2. Development and validation of a novel nutrition-based nomogram to predict prognosis in pancreatic cancer patients receiving first-line systemic chemotherapy from three centres.;2023-10-30
3. Case Report on the Five-year Survival and Complete Response of a Patient with Pancreatic Cancer Treated with Integrative Medicine;The Journal of Internal Korean Medicine;2023-06-30
4. The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy;Nutrients;2019-05-22
5. Review of Domestic Research on Korean Medicine for Pancreatic Cancer;The Journal of Internal Korean Medicine;2019-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3